Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.


  1. Búsqueda avanzada de patentes
Número de publicaciónUS2561071 A
Tipo de publicaciónConcesión
Fecha de publicación17 Jul 1951
Fecha de presentación21 Sep 1949
Fecha de prioridad21 Sep 1949
Número de publicaciónUS 2561071 A, US 2561071A, US-A-2561071, US2561071 A, US2561071A
InventoresPrisk Howard Conley
Cesionario originalPrisk Howard Conley
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Holder for subcutaneous administration of medicaments
US 2561071 A
Resumen  disponible en
Previous page
Next page
Reclamaciones  disponible en
Descripción  (El texto procesado por OCR puede contener errores)

July 17, 1951 H. c. PRISK 2,561,071

HOLDER FOR SUBCUTANEOUS ADMINISTRATION OF MEDICAMENTS Filed Sept. 21, 1949 I 3mm 15! Pris/6 (Etern y Patented July 17, 1951 HOLDER FOR SUBCUTANEOUS ADMINIS- TRATION OF MEDICAMENTS Howard Conley Prisk, Westerville, Ohio Application September 21, 1949, Serial No. 116,963

3 Claims. 1

This invention is concerned with an improved device for holding and applying liquid pharmaceutical or biological compounds in direct contact with the surface of the skin for subcutaneous absorption into the human system.

It is common medical practice to introduce intravenously various preparations or medicaments, such as insulin, hormones, penicillin and.

many other preparations, including steroidal hormones, anti-biotics and the like, into the human system. Usually this operation requires the services of a physician, a graduate nurse or other similarly skilled technician, although self-administration is feasible and often practiced, as in the case of patients affected with diabetes. The use of hypodermic syringes in effecting such injections is disagreeable to many patients, even when handled by a skilled operator. The other alternative is the oral administration of preparations admitting of introduction into the alimentary tract. This method, however, is not altogeher satisfactory, in that certain preparations are destroyed, or their value substantially diminished, during passage through the alimentary tract. Also, this method is objectionable to many physicians in that dependence must be placed on the patient to self-administer medicines in the required quantities at definite intervals of time.

In accordance with the present invention, a

medicament in liquid form is contained in a carrier device which through adhesive means is placed on the body with the liquid medicament contained therein in direct contact with the outer surface of the skin, the body of the carrier being sufficiently flexible to conform with the movements of the human body or that region of the latter to which the carrier is applied, the carrier further including a flexible cap which collapses under atmospheric pressure as the medicament is absorbed or otherwise penetrates into the systerm.

I am aware that many patents have been granted on devices employed as surgical dressings or adhesive bandages, or in applying various medicaments to locally affected area such as wounds, cuts, burns, lacerations, etc. My present device is not concerned with the treatment of such localized afliictions, but is intended for introducing liquid pharmaceutical preparations into the blood stream through the skin. In other words, the device of the present invention acts as an instrument in a way comparable with that of the hyprodermic syringe, the difference being that whereas the hypodermic syringe pierces the skin and deposits a liquid directly into the body cavity, my device permits the liquid to enter said cavity slowly by absorption or direct penetration. In this way, a slow measured introduction of the medicament takes place with my improved device, which enables the human system to absorb and utilize the medicament at all times in proper quantities, instead of applying, as in the case of a hypodermic syringe, an over dosage at one injection and allowing the injection to diminish as the body functions. My device is also an improvement over administering medicines by the mouth, as its avoids deterioration and loss of the beneficial constituents of such medicines as a result of their attack by gastric juices and other bodily processes.

For a further understanding of the invention, reference is to be had to the following description and the accompanying drawing, wherein:

Fig. 1 is a vertical transverse sectional view taken through a medicine administering and holding device formed in accordance with the present invention; the device being shown in its complete form for holding in a sealed state therein biological or pharmaceutical solutions;

Fig. 2 is a similar view disclosing the device as it appears when applied to the surface of the skin;

Fig. 3 is a perspective view of the device.

Referring to the drawings, my improved medicine holding and administering device comprises a capsule 0, formed to provide a base ring 5, which may be composed of a fabric such as crinoline or other fibrous material, woven or matted, to possess stifiness but with a sufiicient degree of flexibility so that it will conform to the movements of that part of the body to which it is applied. The under surface, at least, of the ring 5 is coated with a pressure-sensitive adhesive, such as a rubber-base adhesive, by which the capsule is maintained in an applied position on the outer surface of the skin, and also to separably secure thereto a removable sealing strip 6, the latter being separated from the ring 5 immediately before the capsule device is applied to the skin.

Mounted on the ring 5 is the peripheral edge 1 of a cap 8. This cap is formed preferably from a flexible liquid-resisting material, for example, a sheet of regenerated cellulose such as cellophane, or one of the chlorinated rubbers known commercially as Pliofilm or tensolite. The cap 8 in association with the ring 5 and the sealing strip 6 provides a cavity within the capsule adapted for the reception of a medicament 9 in liquid form, the specific composition or uses of which being unimportant insofar as the present invention is concerned, except their ability to penetrate the human skin.

In the use of my improved capsule device, the base strip 6 is removed at the time of its application, so that the adhesive-bearing surfaces of the ring may be applied directly to the skin, as shown in Fig. 2. In this way, the liquid body 9 comes into direct contact with the skin so that it may be absorbedrintothe system; As the liquid body is absorbed, the cap 8 responds to atmospheric pressure and collapses, maintaining at all times close contact with the body of liquid vacua or sub-atmospheric pressures.

Thus with the use of the caps le,forming.the.

present invention, the rate of introduction of a and A precluding the formation within the capsule of' of the user of the device and a physician is assured that a patient is receiving a given medicament in" proper quantities. The. device -;eliminates the-necessity for cleaning and sterilizing hypodermic needles and overcomes one-of the difii'culitiesor'particular objectionsso frequently encountered in the self -administering of various medical compounds. 1 I

The medicament contained in the cap portion ofthe -applicator is preferably admixed. or dissolved in a compound such-as propylene glycol,

ethylene glycol, alcohol or a saline solution. Alsov there may be maintained in the solution-an electrolyte or catalyst which renders. the. region. or

skinuor membrane towhich the device is applied morereadilyprmeable-to the passage 'of the liq-. uid medicaments through dilation. ofs-dermal pas-- sages. Such anelectrolyte or catalyst may consist of" dilute hydrochloric acid in various: con.- centrations:- Other compoundssuitable for effecting such .dialysiss may include magnesium sulphate or sodium. chloride; Preferably, the, accompanying' article or container of the present inventionisapplied to a. thin part of the human skin, as in regions adjacent to body joints, as the shoulder, elbow or thelikep Various changes may be; made in my device without departing from the: spirit; and scope of.

the invention as the same has been defined in the the; upper surface of'said base member to overliethe'openin'g therein, said cap providing a cavity for the reception of a medicament, an adhesive applied to the under surface of said-base'member, and a removablesealing strip normally attached tothe-base member-by said adhesive and confining; said medicament within-the cavity of said 4 cap, said strip being removable from its sealing association with said base member to open the bottom of said cavity and the opening in said base member, whereby to enable the medicament contained within the cap to contact directly a selected region of the skin around which the device is positioned, the flexibility of the cap being such as to enable the same to flex inwardly to maintain closecontact thereof with the medicament as the volume of the latter progressively decreases in said cavity through absorption in the skin tissue.

2. Medicament holding and applying means comprising: a casing embodying a base and a fiexiblewalled cap, the latter forming a cavity for the reception of a medicament, and a removable sealing strip: normally. attached to the base, said strip beingremovable from its sealing association with said base to open the bottom of said cavity, thereby enabling the medicament contained within the cap to contact'directly a sealing region of the-skin around which the device is positioned;

the fiexibility of-the c'ap'bein'g such as to enable the walls thereof to flex: inwardly and: maintain.

close contact with the medicament as the supply.

humannbody for subdermali absorption comprise;

ing: :a base strip havingan under sidecoated with an adhesive, said stripubeingv formed intermedi. atelyL- thereof with i an opening; .a flexible walled.

cap .securedtonthe uppermsurfacepofi said basestrip toioverlie the-opening therein, said cap pro.- viding acavity forthe reception of-the medicarment, and a removable (sealing strip normally atrta-ched toxthe base member by: said adhesiveand, confining said medicamentwithin said cap, said strip being removable from; its adhesive: ass0cia--; ti0n;;with-. said'base-strip' to enable the medicament'containedwithinthecap to contact directly a selected region, of? the .skin, around which the deviceis positioned, theflexibility ofthematerial forming .thecap being such; 'asto enablesame toflex? inwardly 'tor maintainclosepressure contact with the-,medicament as; the volume ofthe latter progressively decreases in said- 'ca vity through absorptionin the skin tissue. and upon the presence; of anyatmospheric pressure differential on the inner and outer surfaces of the cavity.


REFERENCES. CITED The following references are of record in the file of this patent:

UNITED STATES PATENTS Number Name- Date 720,812 Johnson Feb. 17, 1903; 2,443,140

Larsen June 8, 1943-

Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US720812 *12 Ene 190117 Feb 1903Robert W JohnsonVaccination-shield.
US2443140 *11 Abr 19468 Jun 1948Robert E LarsenBoil cup
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US2817335 *10 Jun 195524 Dic 1957Thompson Thalmer JBandage and dressing
US3053255 *16 Dic 195811 Sep 1962Meyer FriedrichProcess of percutaneously administering exact doses of physiologically active agents and composite unit therefor
US3651932 *9 Oct 196928 Mar 1972Zahn Porzellan Kge Muhbauer &Duplex capsule for dental filling material
US3837340 *4 Jun 197324 Sep 1974Lilly Co EliDevice for administering immunication against virus
US4127339 *19 Oct 197628 Nov 1978Malacheski Joseph JDispenser package for fluent material
US4232671 *23 Jun 197811 Nov 1980Crump Charles LSafety eyewash package and container therefor
US4341208 *14 Jul 198027 Jul 1982Whitman Medical CorporationMoisture-retentive covering for ointment application
US4585452 *12 Abr 198329 Abr 1986Key Pharmaceuticals, Inc.Transdermal systemic dosage forms
US4619652 *19 Ago 198528 Oct 1986Alza CorporationDosage form for use in a body mounted pump
US4649075 *9 Ago 198410 Mar 1987Leonora JostTransdermal and transmucosal vortexed foam devices and the method of making
US4655766 *17 Abr 19867 Abr 1987Alza CorporationFluid imbibing pump with self-regulating skin patch
US4687481 *3 Mar 198618 Ago 1987Biotek, Inc.Transdermal drug delivery system
US4710191 *16 Dic 19851 Dic 1987Jonergin, Inc.Therapeutic device for the administration of medicaments
US4801587 *2 Mar 198731 Ene 1989Gene VossImpotence ointment
US4812305 *9 Nov 198714 Mar 1989Vocal Rodolfo SWell medicine strip
US4822617 *10 Abr 198718 Abr 1989Elan Corporation P.L.C.Drug delivery device
US4877618 *18 Mar 198831 Oct 1989Reed Jr Fred DTransdermal drug delivery device
US4904475 *24 Feb 198727 Feb 1990Alza CorporationTransdermal delivery of drugs from an aqueous reservoir
US4917688 *27 Jun 198817 Abr 1990Nelson Research & Development Co.Bandage for transdermal delivery of systemically-active drug
US5139023 *2 Jun 198918 Ago 1992Theratech Inc.Apparatus and method for noninvasive blood glucose monitoring
US5291887 *2 Jun 19928 Mar 1994Anesta CorporationApparatus and methods for noninvasive blood substance monitoring
US5498417 *12 May 199412 Mar 1996Coating Sciences, Inc.Transdermal delivery of appetite suppressant drug
US5962011 *24 Jun 19975 Oct 1999Schering-Plough Healthcare Products, Inc.Device for delivery of dermatological ingredients
US66769616 Mar 200213 Ene 2004Automated Carrier Technologies, Inc.Transdermal patch assembly
US797686712 Dic 200312 Jul 2011Schering-Plough Healthcare Products Inc.Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US820673812 Sep 200326 Jun 2012Corium International, Inc.Hydrogel compositions with an erodible backing member
US82734057 Oct 201125 Sep 2012A.V. Topcheiv Institute of Petrochemical Synthesis, Russian Academy of SciencesWater-absorbent adhesive compositions and associated methods of manufacture and use
US848105924 Jun 20099 Jul 2013A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of SciencesHydrogel compositions
US848107129 May 20129 Jul 2013Corium International, Inc.Hydrogel compositions with an erodible backing member
US854102117 May 200424 Sep 2013A.V. Topchiev Institute Of Petrochemical SynthesisHydrogel compositions demonstrating phase separation on contact with aqueous media
US861764724 Ago 201231 Dic 2013A.V. Topchiev Institutes of Petrochemical Synthesis, Russian Academy of SciencesWater-absorbent adhesive compositions and associated methods of manufacture and use
US865820131 Ene 200525 Feb 2014Corium International, Inc.Rapidly dissolving film for delivery of an active agent
US87284451 May 200220 May 2014A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of SciencesHydrogel Compositions
US874133112 Jun 20133 Jun 2014A. V. Topchiev Institute of Petrochemicals Synthesis, Russian Academy of SciencesHydrogel compositions with an erodible backing member
US875366920 Ago 200717 Jun 2014A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of SciencesTwo-phase, water-absorbent bioadhesive composition
US878487914 Ene 201022 Jul 2014Corium International, Inc.Transdermal administration of tamsulosin
US88219015 Abr 20102 Sep 2014A.V. Topchiev Institute Of Petrochemical Synthesis Russian Academy Of SciencesMethod of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US88409185 Feb 200323 Sep 2014A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of SciencesHydrogel compositions for tooth whitening
US90847232 Jun 201421 Jul 2015A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of SciencesHydrogel compositions with an erodible backing member
US20040105834 *12 Sep 20033 Jun 2004Corium InternationalHydrogel compositions with an erodible backing member
US20040166147 *12 Dic 200326 Ago 2004Schering-Plough Healthcare Products, Inc.Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
USRE4414510 Jun 20059 Abr 2013A.V. Topchiev Institute Of Petrochemical SynthesisPreparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
EP0107575A1 *12 Oct 19832 May 1984Laboratoires Fournier S.A.Percutaneous administration device of the active principle
EP0123539A2 *19 Abr 198431 Oct 1984James Chester BrenemanImmune responses to ingestible substances
Clasificación de EE.UU.424/449
Clasificación internacionalA61K9/70
Clasificación cooperativaA61K9/7084
Clasificación europeaA61K9/70E2D